Most Recent Discussions
Oct 25 2023
Re: Nanodropper
/Dr. H, not sure how you would get the drop out of bottle if you put a nano dropper on it, i would think that you would need to squeeze the bottle in order to get it out. Can't
read more
Jan 05 2023
Re: Nanodropper
I would use it for fluress(and other brands for Goldmann tonkmetry),considering their crazy high prices but I am not sure if the nanodropper tip would fit the glass bottles.
Dec 15 2022
Re: Nanodropper
I would be curious if anyone else is using this tech. We ordered a few samples to use in our clinic, with our dilating drops, but I have yet to recommend it to patients using glaucoma meds (or Vuity
read more
Clinician Topics
- Glaucoma Watch
- Interesting Glaucoma Cases
- From Ocular Hypertension to Glaucoma: How to Predict Conversion
- Neckties and IOP: The Controversy Continues
- Introduction to the National Glaucoma Society
- Case Presentation: Optic Nerve Imaging
- NGS Residency Award and Lecture
- Optic Nerve Head Measurements with the HRT III
- Case Presentation: Laser Imaging Detects Early ON Damage
- Is the Optic Disc "Sinking" or "Cupping" in Glaucoma?
- Interview with Dr. Barry Barresi
- Glaucoma Continuum
- Undiagnosed Open Angle Glaucoma: The Thessaloniki Eye Study
- The Prevalence of Open-angle Glaucoma Among Blacks and Whites 73 Years and Older
- Altered Nitric Oxide System in Patients with Open-Angle Glaucoma
- Oxidative Stress in Glaucoma: A Burden of Evidence
- Gonioscopy Videos
- Glaucoma Risk and the Consumption of Fruits and Vegetables in Older Women
- Programs to Optimize Adherence in Glaucoma
- Corneal Hysteresis
- Treatment Goals in Glaucoma
- Visual Field Interpretation
- Study Questions link between Glaucoma and Alzheimer's Disease
- Checking Color Vision
- Glaucoma Medications
- IOP Asymmetry as Glaucoma Risk Factor
- Glaucoma Risk Calculators
- Dr. David Calkins Discusses Catalyst for A Cure
- Smart Phone Biosensor
- Handheld OCT
- Sustained Release IOP Therapies
- Introduction to Corneal Hysteresis
- FDT Perimetry
- Visual Fields Overview
- National Glaucoma Symposium 2017
- Gonioscopy Slides from 2017 National Glaucoma Symposium
- Measuring Corneal Hysteresis
- XEN Glaucoma Implant Video
- Corneal Hysteresis
- Glaucoma Quality of Life Measures
- Corneal Hysteresis: The A1C of Glaucoma
- Predicting Progression
- New Developments in Glaucoma Management
- Longitudinal Study of Corneal Hysteresis
- National Glaucoma Symposium 2018
- DREAM Study
- OIS at SECO
- National Glaucoma Symposium Cape Cod
- Is Glaucoma a Two-Pressure Disease?
- ICD Stage Definitions
- Visual Fields and Progression
- OCT: The Basics
- Co-Managing Glaucoma Surgery
- Normal Tension Glaucoma
- The Importance of Visual Fields
- Corneal Hysteresis
- Using OCT in Glaucoma Management
- The LiGHT Study
- Durysta Overview
- Options in Glaucoma Surgery
- Telemedicine in Glaucoma
- Glaucoma Medications
- New Visual Field Primer
- Glaucoma Risk Factors
- Drug Therapy for the Ocular Surface in Glaucoma
- OCT Overview and Applications
- Yoga as Adjunct Glaucoma Therapy
- Cataract Surgery May Lower Risk for Dementia
- Parapapillary Atrophy
- Angle Closure Glaucoma
- Congratulations to Dr. Thimons
- Corneal Influences on IOP
- In Your Office
- Glaucoma Flowsheet
- Tonometer Calibration
- Pachymetry Coding
- BCBS Coverage of SCODI Services
- Expanded Coverage of Glaucoma Screening Services
- Coding Update: 92135 Deleted and Replaced
- ABO Certification Review Materials
- Small Fee Reduction in CMS Payments in 2015
- Moist Heat Compresses
- Information about Omega-3s
- Lighthizer Surgical Procedure Set
- Glaucoma Website for Patients
- Beware of Phone Scam Posing as DPH or DEA
- Tonography
- Patient Assistance Programs
- Plaquenil Reporting Form
- World Optometry Day
- Pharmacology Update
- Extravan: Alcon Pharmaceuticals
- Mechanism of IOP Reduction with Travoprost
- Floater Intervention Study
- Nanodropper
- Chart of Glaucoma Therapies
- Hydroxychloroquine Toxicity
- Timolol
- Upneeq Drops for Ptosis
- Tetracaine Study
- Clinical Guidelines
- CCT: Is is time to say YES?
- The Role of CCT in Glaucoma Patients
- More CCT
- The Paradox of IOP
- Should We Treat All Ocular Hypertensives?
- Beta Blockers in Glaucoma Management
- Re-Defining Ocular Hypertension
- Implications of Macro-Disc Asymmetry in Glaucoma Suspects
- Nine-Year Changes in Intraocular Pressure: The Barbadoes Eye Studies
- CyPass Clinical Recommendations
- Optic Disc Cupping and Neuroimaging
- Industry News
- New FDA Approval for Lumigan
- Alcon's Travatan Z Solution Receives FDA Approval
- Alcon's Travatan Z and Systane Use Different Preservatives
- Pfizer Sponsors New "All Eyes on Glaucoma" Website
- CLIA Waivers
- Bausch + Lomb New Glaucoma Drug
- Glaukos iStent inject FDA Approved
- Alcon Withdraws CyPass Stents
- Nuretin Omega-3 Supplements
- Rocklatan FDA Approved
- Vivid Vision Perimetry
- Falck Multifunction Device
- Zeiss Medical Device Recall
- Sustained IOP Reduction with iDose TR